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Editor’s key points
† The issue of neurotoxic and
neuroplastic effects of general
anaesthesia is extremely
important.
† The authors have provided an
overview of preclinical evidence
of long lasting neuronal effects
of general anaesthesia.
† Neuronal modulation by general
anaesthesia can negatively
affect cognition, especially in
the young and the elderly.
† This article provides up-to-date
knowledge, and direction for
future developments and
research, in this area.
Although previously considered entirely reversible, general anaesthesia is now being
viewed as a potentially significant risk to cognitive performance at both extremes of
age. A large body of preclinical as well as some retrospective clinical evidence suggest
that exposure to general anaesthesia could be detrimental to cognitive development
in young subjects, and might also contribute to accelerated cognitive decline in
the elderly. A group of experts in anaesthetic neuropharmacology and neurotoxicity
convened in Salzburg, Austria for the BJA Salzburg Seminar on Anaesthetic
Neurotoxicity and Neuroplasticity. This focused workshop was sponsored by the British
Journal of Anaesthesia to review and critically assess currently available evidence
from animal and human studies, and to consider the direction of future research. It
was concluded that mounting evidence from preclinical studies reveals general
anaesthetics to be powerful modulators of neuronal development and function,
which could contribute to detrimental behavioural outcomes. However, definitive
clinical data remain elusive. Since general anaesthesia often cannot be avoided
regardless of patient age, it is important to understand the complex mechanisms and
effects involved in anaesthesia-induced neurotoxicity, and to develop strategies for
avoiding or limiting potential brain injury through evidence-based approaches.
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There is growing concern that exposure to general anaes-
thetics can lead to subsequent learning impairment and
memory deficits and behavioural abnormalities in young sub-
jects, and to accelerated cognitive decline in the elderly.
British Journal of Anaesthesia 111 (2): 143–51 (2013)
Advance Access publication 30 May 2013 . doi:10.1093/bja/aet177
& The Author [2013]. Published by Oxford University Press on behalf of the British Journal of Anaesthesia. All rights reserved.
For Permissions, please email: journals.permissions@oup.com
A group of physicians and scientists who are experts in anaes-
thetic neuropharmacology and neurotoxicity convened in
June, 2012 at the BJA Salzburg Seminar on Anaesthetic Neuro-
toxicity and Neuroplasticity in Salzburg, Austria for a workshop
sponsored by the British Journal of Anaesthesia. The group met
for several days of intense discussions and workshops to review
and challenge currently available evidence from animal and
human studies, and to consider the direction of future re-
search. The discussions identified the following points as
being crucial for the evolving understanding of anaesthetic
neurotoxicity.
Anaesthesia-induced neurotoxicity and
neuroplasticity in the developing brain
Anaesthesia-induced developmental neuroapoptosis
The panel recognized that two critical factors determine an-
aesthetic neurotoxicity: the stage of brain development at
the time of exposure, and the degree of anaesthetic exposure,
which includes both exposure frequency and cumulative an-
aesthetic dose. The specific anaesthetic drug utilized, health
status, or the specific procedure all represent possible second-
ary factors. Animal studies provide clear evidence that the se-
verity of pathomorphological changes indicative of extensive
neuroapoptosis or impaired synaptic development coincides
with extensive synapse formation (i.e. synaptogenesis).1 It is
noteworthy that the peak period of synaptogenesis does not
occur at the same time in all brain regions even within the
same species. Thus, different brain regions are vulnerable at
different developmental periods. For example, exposure to a
variety of anaesthetics causes severe apoptosis at postnatal
day (PD) 7 in rat thalamus, hippocampal region CA1, and neo-
cortex while other neuronal populations, such as dentate
gyrus, are not substantially affected at this developmental
time point (AW Loepkeetal., unpublished observations).2 How-
ever, following anaesthetic exposure at PD 21, substantial
neuroapoptosis was observed in dentate gyrus, while neocor-
tical vulnerability had dramatically subsided.
Even within the same brain region, vulnerability may not be
uniform. For example, at PD 7 anaesthesia-induced neuro-
apoptosis within neocortex is highest in superficial layers II
and III.3 Regional differences in anaesthetic toxicity could
reflect regional differences in synaptogenesis during early
stages of brain development. Moreover, different neuronal sub-
types may vary in their vulnerability to anaesthetics, as demon-
strated, for example, by greater susceptibility of glutamatergic
and GABAergic neurones than cholinergic neurones in neocor-
tex of 7-day-old rats.4
Effects of general anaesthetics on neuronal network
assembly
In addition to anaesthesia-induced developmental neuro-
apoptosis, the effects of general anaesthetics on neuronal
network assembly were also discussed. To this regard, several
research groups have shown that anaesthesia exposure
during the early stages of the brain growth spurt rapidly
leads to a significant and persistent decrease in the number
of synapses in several brain regions in rodents.5 – 7 In contrast,
these same drugs induce a lasting increase in the number of
synaptic contacts when administered at later stages
(between PD 15 and PD 30) of the peak synaptogenic period.7 8
g-Aminobutyric acid (GABA) is the major inhibitory neuro-
transmitter in the brain, and GABA subtype A (GABAA) receptors
are primary targets for most clinically used general anaes-
thetics. Activation of GABAA receptors can generate a depolar-
izing or excitatory response during early stages of brain
development. It has been suggested that changes in the
morphology and density of synaptic spines, a histological cor-
relate of synaptogenesis, correlate with excitability in the
developing brain. During initial phases of the brain growth
spurt, GABA acts as an excitatory neurotransmitter, and
GABAA receptor-mediated membrane depolarization is a key
regulator during early stages of both excitatory and inhibitory
synaptogenesis in developing neurones.9 10 At later stages of
the peak synaptogenic period, there is a functional shift
towards the hyperpolarizing and thus inhibitory effects of
GABAA receptor-mediated neurotransmission. The switch
from excitatory to inhibitory GABAergic neurotransmission cor-
relates temporally with changes in the neurone-specific chlor-
ide potassium symporter responsible for establishing the
chloride gradient in neurones and maintenance of low intracel-
lular chloride concentrations necessary for inhibitory chloride
influx. Neuronal potassium-chloride cotransporter (KCC) ex-
pression undergoes a developmental switch from the NKCC1
sodium-potassium-chloride cotransporter, an immature form
that promotes neuronal excitability, to a mature form, KCC2,
that promotes neuronal inhibition.11 KCC2 expression
increases markedly during the second postnatal week in the
rodent cerebral cortex,12 and from the 30th gestational week
in humans.13 It is, thus, tempting to speculate that
anaesthesia-evoked developmental toxicity depends, at least
partly, upon the expression levels of KCC2 in the central
nervous system (CNS). It is also recognized that in the normal
adult neurones, a large and persistent increase in GABAA recep-
tor conductance can cause a biphasic response such that the
initial membrane hyperpolarization is followed by depolariza-
tion. The depolarization is due to the accumulation of intracel-
lularchloride and the resulting collapse of the chloride gradient
as well as effluxof bicarbonate ions.14 During periods of intense
GABAA receptor activation (as occurs during exposure to most
anaesthetics) such events could lead to increased excitability
of neurones even in the presence of adult levels of the
co-transporter KCC2.
Anaesthetic effects on neurogenesis
When the volatile anaesthetic isoflurane was administered for
35 min every day for 4 days to both very young and adult rats
and mice, the young but not adult rodents showed impaired
memory performance, and the deficits became more pro-
nounced as the animals grew older.15 Memory deficits were
paralleled by a decrease in the hippocampal stem cell pool
and persistently reduced neurogenesis. Neurogenesis
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continues throughout life in two discrete brain regions, the
dentate gyrus of the hippocampus and the subventricular
zone. In the hippocampus, the formation of new neurones is
thought to be important for memory and learning. The
isoflurane-induced loss of stem cells and reduction of neuro-
genesis occurred without any overt signs of cell death. The
underlying mechanisms remain to be identified. One possibility
is that dying cells are cleared by microglia before markers of cell
death can be detected.16 Another possibility is that under
pathological conditions progenitor cells differentiate into
glial cells instead of neurones.17 A third possibility is that the
normal, age-related disappearance of hippocampal neural
stem cells,18 the appearance of new astrocytes, and the
decline in the production of new neurones may be accelerated
by isoflurane. Regardless of the underlying mechanism, it
remains to be shown why the isoflurane-induced loss of stem
cells and reduction of neurogenesis occurred in young but
not in adult brains.
Role of neurotrophic factors in anaesthetic effects on
synaptic density
It appears that neurotrophic factors in general, and brain-
derived neurotrophic factor (BDNF) in particular, are involved
in isoflurane- and propofol-induced reductions in synapse
density in the developing hippocampus. A model that has
been widely used to study neurotoxicity involves the in vitro
exposure of primary cultured hippocampal neurones to either
1.4% isoflurane or 2 mM propofol for 4 h. Both propofol and
isoflurane cause significant reductions in synaptic density.
This is accompanied by activation of RhoA and the growth
factor receptor p75NTR as part of a cascade leading to actin
depolymerization, loss of microtubules, and impairment of
axonal transport. When isoflurane was co-administered
with Pep5, an inhibitorof the p75 receptor, the effects of isoflur-
ane on synaptogenesis were reduced.5 It is noteworthy that
disruption of microtubules after propofol exposure leads to
inhibition of BDNF trafficking. The microtubule system is cru-
cially important in transporting not only metabolic elements
essential for neuronal survival and development, but also
for the strategic transport of cellular organelles (mitochondria
in particular) from the soma to remote compartments
such as axons and dendritic spines where their presence is
required to ensure proper neuronal function and formation of
circuits.
The role of mitochondria and reactive oxygen species
in anaesthesia-induced neurotoxicity
In the immature brain, anaesthetics and sedatives that
promote GABAA receptor activation result in elevated intracel-
lular calcium, which leads to disturbances in mitochondrial
membrane potential and bioenergetics causing neuronal dys-
function and death.19 20 In particular, propofol, sevoflurane,
and isoflurane (in combination with nitrous oxide and midazo-
lam) increased the production of reactive oxygen species
(ROS).20 21 As hyperoxia worsens ischaemic brain damage
in both immature and mature animals,22 23 avoidance of
unnecessary hyperoxic ventilation or administration of antiox-
idants while under anaesthesia may help protect against an-
aesthetic neurotoxicity.24 Oxidative stress and mitochondrial
dysfunction in both the heart and the brain can also be
reduced by anaesthetic preconditioning,25 – 27 possibly
mediated by stimulation of sub-toxic ROS production and sub-
sequent expression of antioxidant gene products.28
Even under normoxic conditions, many anaesthetics cause
a significant increase in ROS that leads to increased neuronal
lipid peroxidation and neuronal deletion in vulnerable brain
regions such as the subiculum, a part of the hippocampus
proper.21 To assess the functional importance of ROS
up-regulation in anaesthesia-induced cognitive impairment,
the protective role of ROS scavengers was explored. Exposure
of rat pups to general anaesthesia at PD 7 caused significant
cognitive deficits. However, if pups were also treated with
either EUK-134, a synthetic mimic of superoxide dismutase
and catalase, or R(+)pramipexole (PPX), a mitochondrial pro-
tectant and ROS scavenger, cognitive development was
almost indistinguishable from that of animals not exposed to
the anaesthetic.21 The results suggest that early protection
around the time of anaesthesia exposure using agents that
can prevent mitochondrial damage and ROS up-regulation
could be very important in alleviating anaesthesia-induced de-
velopmental cognitive impairment. Similar protection with anti-
oxidants or mitochondrial enhancers has been noted for the
neurohistological effects produced by anaesthetics.29
Nitrous oxide neurotoxicity
Neurotoxicity induced by nitrous oxide-induced block of
N-methyl-D-aspartate (NMDA) receptors is manifest by
massive swelling of neuronal organelles including mitochon-
dria and endoplasmic reticulum.30 Nitrous oxide also increases
plasma homocysteine caused by oxidation of methionine
synthase. As levels of homocysteine can be easily measured
in blood, they can be used as biomarkers of nitrous
oxide-induced modulation of methionine synthase activity.
After an 8 h exposure to nitrous oxide, an eight-fold increase
in blood homocysteine levels could be detected.31 32 This in-
crease was prevented by continuous infusion of vitamin B12,
which is an enzyme co-factor of methionine synthase. Future
research aims to assess how and whether this effect is relevant
to short-term neurocognitive outcomes, long-term neurocog-
nitive outcomes, or both.
Role of glial cells in developmental anaesthetic
neurotoxicity
Glial cells are crucially important during early stages of brain
development, and are important anaesthetic targets,33 34 so
the role of anaesthesia in modulating glial function and
growth was considered. Using primary astroglia cultures from
E18 rat embryos, it was found that isoflurane causes marked
reduction in glial fibrillary acidic protein (GFAP) and b-tubulin
staining, suggestive of isoflurane-induced impairment of
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astroglial cytoarchitecture similar to that in previously pub-
lished reports. However, unlike previous findings, which sug-
gested that isoflurane impairs astroglial proliferation, newer
evidence did not find an effect on astroglial survival, cyto-
chrome c release, caspase-3 activation, or proliferation.35
The apparent discrepancy was attributed to several factors:
age of the cultures, duration of exposure, and dose. Interest-
ingly, the impairment in astroglial proliferation was found in
primary astroglial cultures obtained from 1- to 2-day-old rat
pups that were exposed to isoflurane for 24 h (as opposed
to 4 h) and at a concentration of 3% (as opposed to 1.4%).36
Nevertheless, the common finding, regardless of the dose or
duration, is that isoflurane exposure impairs glial cytoarchi-
tecture in immature astrocytes, which could result in
impaired morphological development and proliferation.
Role of surgery, inflammation, and pain in
anaesthesia-induced developmental neurotoxicity
Although skin incision and formalin injection are painful
stimuli, they cannot simulate true surgical conditions
where, in addition to intense nociception, the role of inflam-
mation, infection, blood loss, and fluid shifts can be substan-
tial. Available evidence suggests that surgical stimulation
worsens isoflurane-induced developmental neuroapoptosis
and anaesthesia-induced cognitive deficits.37 However, con-
current inflammatory peripheral noxious stimulation with
ketamine anaesthesia attenuated the increased neuroapop-
tosis compared with ketamine anaesthesia without noxious
stimulus.38 Although the mechanisms underlying these
contrasting effects remain to be deciphered and are likely
complex, these emerging findings suggest that surgery is an
additive if not synergistic propagator of anaesthesia-induced
developmental neurotoxicity.37 For example, the key pro-
inflammatory factor interleukin 1 beta (IL-1b), which is ele-
vated during surgery, increases the trafficking of GABAA
receptors to the surface of neurones in the hippocampus.39
The resulting increase in surface expression of GABAA recep-
tors on neurones might increase neurotoxicity associated
with activation of these receptors.
Role of complement activation in anaesthesia
Molecules of the inflammatory cascade, including comple-
ment, play a vital role in the establishment and modification
of synaptic connections during development.40 41 Along
these lines, emerging evidence suggests that isoflurane acti-
vates the complement cascade and inflammatory pathways
via modulation of C1q+ and C3 and by inducing a variety
of cytokines and chemokines. Activation of the comple-
ment cascade occurs in the absence of apoptosis or overt
changes in microglial number or morphology; effects on
C1q appeared after relatively short exposure to isoflurane
(as short as 2 h). These results suggest that anaesthetic
effects could be much more complex than activation of apop-
tosis during synaptogenesis (Culley DJ and Crosby C, unpub-
lished observations).
Developmental anaesthetic neurotoxicity in
non-human primates
Exposure of young rhesus monkeys to ketamine at PD 5/6 for 24
h induces significant apoptosis as detected with caspase-3,
Fluoro-Jade and silver staining.42 In a recent study, rhesus
monkey neonates (PD 5 or 6) were exposed to 1% isoflurane
combined with 70% nitrous oxide for 8 h and control
monkeys were exposed to room air only. One day later, a posi-
tron emission tomography (PET) imaging agent ([18F]N-2-
(2-fluoroethoxy)benzyl)-N-(4-phenoxypyridin-3-yl)acetamide
([18F] FEPPA) that labels cellular markers indicatative of neur-
onal damage and brain cell death) was injected for microPET/
computed tomography imaging over the next 2 h, at 7 and
21 days, and at 6 months after anaesthetic exposure. On
days 1 and 7 after exposure, uptake of [18F] FEPPA was signifi-
cantly increased in several brain regions, but by day 21 and at
6 months uptake was not different from controls. These data
suggest that PET imaging can be used to describe the time
course of anaesthetic-induced neurotoxicity in a minimally
invasive manner in the same animal.43 Exposure to ketamine
causes significant upregulation of NMDA receptors, in particu-
lar the NMDA receptor subunit NR1. Young cultured rat fore-
brain neurones exposed to ketamine showed a similar and
dose-dependent up-regulation of mRNA for the NR1 subunit
and, when NR1 subunit up-regulation was blocked with NR1
antisense RNA, ketamine-induced cell death was prevented.44
In addition to pathomorphological indices of ketamine-
induced developmental neuroapoptosis, there is emerging
evidence that cognitive behaviour of non-human primates is
impaired as well. Assessment with an Operant Test Battery
(OTB) revealed that ketamine causes long-term (perhaps
permanent) impairment of learning and memory. Ketamine-
treated primates also suffer from lower motivation scores,
which could, at least in part, account for lower learning
scores. However, effects on motivation do not lessen concerns
regarding long-term behavioural sequelae of early exposure to
general anaesthesia.45
The window of vulnerability to anaesthetic-induced
damage
Time windows of vulnerability must be carefullyassessed when
comparing vulnerability to anaesthetics between species. For
example, brain maturation in monkeys at gestational age
120 days (during their last trimester in utero) is generally
accepted as comparable with that in the first week of postnatal
life in humans (0–6 days of age). On the other hand, brain
maturation at PDs 6 and 35 in monkeys corresponds to that
of 6 and 12 months of age, respectively, in human
infants.46 When non-human primates were exposed to isoflur-
ane, ketamine, or propofol either in utero (120 days of gesta-
tional age) or postnatally (6 days of age), the patterns of
neuronal damage in the brain differ in accordance with previ-
ously noted findings that brain region vulnerability depends
on the stage of development. For example, in non-human pri-
mates the fetal apoptosis pattern after ketamine anaesthesia
was more widespread and involved the cortex, basal ganglia,
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thalamus, amygdala, cerebellum, and brainstem, whereas the
neonatal apoptotic pattern after the same ketamine anaes-
thetic seemed to be more pronounced in cortical and basal
ganglia grey and white matter compared with other brain
regions.47
In neonatal monkeys, there were agent-specific differences
in the severity of neurotoxicity—isoflurane was more dam-
aging than propofol, and propofol was more damaging than
ketamine in both white and grey matter using caspase-3
staining.48 Agent-specific differences in the degree of anaes-
thetic neurotoxicity were also age-dependent. Ketamine was
more toxic in fetal compared with neonatal brain, whereas
isoflurane was more damaging to the neonatal than fetal
brain. When apoptosis was studied in white matter after 5 h
of isoflurane anaesthesia, significant caspase activation was
noted in premyelinating and myelinating oligodendrocytes in
neonatal monkeys.49 In contrast, astrocytes were not found
to be injured by the anaesthetic exposure.49 At PD 35,
monkeys did not show neuronal cell death after 24 h of keta-
mine anaesthesia.50
When comparing neurotoxicity of different anaesthetics
(i.v. and inhalation) the doses of the different agents require
normalization for potency. A clinically relevant way to ap-
proach this issue is to administer equipotent doses such that
the depth of anaesthesia is comparable. The approach used
thus far has been titration of anaesthetic administration to
achieve the lack of response to a profoundly noxious stimula-
tion to all four extremities without causing any motor response
or an increase in arterial pressure or heart rate of .10% from
baseline, with assessments made every 30 min.
Preliminary results from human studies to assess
neurocognive effects of early anaesthetic exposure
General anaesthetics such as nitrous oxide, sevoflurane, and
isoflurane given to children at ,12 months of age seem to
impair recollection when these children are 6–11 yr old. Recol-
lection is an important component of recognition memory and
is supported by anatomic brain structures that are affected by
anesthesia-induced cell death. When the outcomes of spatial
tasks were explored, young boys were more affected than
young girls, although difficulties with the colour recognition
task were detected equally in boys and girls. The performance
was worse when children were exposed for a longer time
(several hours). It is noteworthy that this preliminary study,
which included 28 children, failed to find a difference
between single and multiple exposures in terms of deficits in
recognition memory (Stratmann et al., unpublished observa-
tions). When recognition memory was tested in a rat model
of anaesthetic neurotoxicity, anaesthesia-treated rats exhib-
ited significant impairment of recollection similar to humans;
but no deficits were detected in another component of recog-
nition memory called familiarity. As familiarity is dependent on
a properly functioning perirhinal and parahippocampal cortex,
the hippocampus and functionally connected areas might be
more sensitive to anaesthesia-induced damage. Additional
large-scale prospective, randomized clinical trials will be
needed to re-examine these findings.
Clinical outcome studies
Although preclinical data regarding anaesthesia-induced
neurotoxicity during early stages of brain development have
been very convincing and highly reproducible in a variety of
species, similar effects in humans are much less certain
because of inherent difficulties in outcome studies.51 Truly de-
finitive studies would require subjects to be exposed to anaes-
thetics without medical necessity. This is not possible because
of obvious ethical issues with designing prospective rando-
mized clinical trials in very young children. Some of the retro-
spective clinical studies looking at long-term behavioural
effects of anaesthesia were collected from patient cohorts
that were exposed to anaesthesia in the 1970s and early
1980s when sophisticated monitoring (pulse oximetry in par-
ticular) was not routinely available. Consequently, concerns
exist that respiratory or haemodynamic disturbances might
not have been detected and remedied in a timely fashion
and, thus, potentially could have contributed to the observed
cognitive deficits. However, hypercarbia or hypoglycaemia, al-
though intuitively presumed to worsen anaesthesia-induced
developmental neurotoxicity, was not observed to affect the
degree of anaesthesia-induced neuroapoptosis in some
animal studies.52 53
Concerns regarding potential developmental neurotoxicity
in humans have to be considered with some delicacy. Surgery
cannot be performed without anaesthesia and is frequently
performed in very young children to treat life-threatening con-
ditions, to avert dangerous health conditions, or to improve
quality of life. The known health risks of not treating these con-
ditions have to be weighed against the potential adverse
effects of surgery with anaesthesia. Given the fact that
current clinical studies do not unequivocally demonstrate im-
pairment of behavioural development, it is possible that
more harm could be inflicted if necessary or timely treatment
is withheld because of concerns regarding early life exposure
to anaesthesia.
Anaesthesia-induced neurotoxicity and
neuroplasticity in the aging brain
The role of anaesthesia in postoperative cognitive
decline in the elderly
Available data suggesting an association between cognitive
decline and anaesthesia exposure in humans are based
mainly on case reports rather than on large-scale prospective
clinical trials. The problem centres on the reliability of diagno-
sis—postoperative cognitive decline (POCD) is not a clearly
defined clinical diagnosis. In the clinical environment, the
concern is based on the subjective assessment of a patient or
his/her family members. Nevertheless, even after short surgi-
cal or diagnostic procedures, up to 47% of elderly patients
will demonstrate cognitive decline 24 h after anaesthesia.54
At the time of hospital discharge, cognitive decline has been
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demonstrated in 31–47% of patients, whereas at 3 months
post-procedure 10% of patients still have evidence of cogni-
tive decline.55 – 57 Several risk factors have been suggested,
such as advanced age, lower educational level, longer duration
of anaesthesia, and higher severity of surgery (e.g. vascular,
orthopaedic, and cardiac). There has been no correlation
between POCD and the type of anaesthesia (i.e. regional or
general), nor wasthere a clearcorrelation with deep or light an-
aesthesia or the specific anaesthetic agents used. Forexample,
some studies suggest that deep anaesthesia (as determined
using bispectral index monitoring) is associated with higher in-
cidence of POCD58 whereas others suggest no association
between the depth of anaesthesia and POCD.59 A pilot study
by Zhang and colleagues60 suggested that perhaps isoflurane
might be more likely to cause POCD when compared with des-
flurane although large-scale studies would be necessary to
confirm this notion.
Current clinical trials focus on the comparison of POCD post-
cardiac surgery on-pump or off-pump.61 Some of the prelimin-
ary findings suggest that off- and on-pump cardiac surgeries
result in approximately the same cerebral oxygen levels with
no difference in long-term POCD with respect to the anaesthet-
ic agent used or the dose administered (Absalom et al., unpub-
lished observations). There was no correlation between slight
hypoxaemia/hypothermia and POCD. Some studies suggest
that hypothermia (core body temperature of 328C), which
necessitates re-warming at the end of surgery, causes dis-
turbed cerebral autoregulation and can result in cerebral
oedema, thus worsening cognitive recovery postoperatively.
Effects of anaesthetics on cognitive function in adult
animals
Studies of adult mice and rats have shown that exposure to
inhaled anaesthetics causes memory deficits that persist
even after the anaesthetics have been eliminated. Memory
deficits for both antegrade and retrograde memory can
persist much longer than expected based on pharmacokinetic
properties. Further, age might exacerbate post-anaesthetic
memory loss.62 63 For example, robust deficits in antegrade
memory are evident in adult mice for up to 48 h after a single
brief (1 h) exposure to isoflurane at 1 minimum alveolar con-
centration.64 65 Only certain types of memory are vulnerable
to anaesthetics. Working memory (required to perform short-
term tasks such as remembering a phone number immediately
after locating it in the phonebook) generally remains intact,65
while long-term memory is impaired. There is some inconsist-
ency here, however, as most studies find working memory is
disrupted while reference memory is intact.63 66 67 Specific sub-
types of GABAA receptors that generate a tonic inhibitory con-
ductance in principle neurones are known to be particularly
sensitive to inhaled68 and i.v.69 anaesthetics might play a key
causal role; preemptive inhibition of a5 GABAA receptors
before exposure to the anaesthetic prevented memory deficits
in mouse models.64 65 Also, administration of a drug that inhi-
bits a5 GABAA receptors after exposure fully restored memory
performance.
Effects of anaesthetic exposure on Alzheimer’s
disease in the elderly
Approximately 8.5 million Alzheimer’s disease (AD) patients
and a much greater number of senior patients who are vulner-
able to AD will need surgical care under anaesthesia annually
around the world. Tau is a highly soluble and hydrophilic
microtubule-associated protein known to play an important
role in AD dementia and neurodegeneration as it is essential
for Ab-mediated neurotoxicity,70 71 tau pathology correlates
with cognitive decline in AD patients.72 73 Tau undergoes very
minimal phosphorylation in the adult brain (,5%), but in AD
brain tau protein is close to 100% phosphorylated and
aggregates.74
Most anaesthetics promote tau hyperphosphorylation in
rodents, albeit indirectly by inducing hypothermia.71 72 Hypo-
thermia has a profound effect on tau phosphorylationvia redu-
cing phosphatase activity.73 Interestingly, repeated exposure
to hypothermic anaesthesia results in both tau detachment
from microtubules and increased aggregation.75 76 However,
anaesthetics per se can have an effect independent of hypo-
thermia as normothermic administration of i.v. anaesthetics
such as propofol77 or sedatives such as dexmedetomidine
(Whittington RA, unpublished observation), result in persistent
tau hyperphosphorylation in mice. Repeated normothermic
administration of volatile anaesthetics to mice results in
either persistent tau hyperphosphorylation with sevoflurane,78
increased Ab aggregation with halothane79 or isoflurane,80
cognitive impairment, or both as determined using the Morris
Water Maze test (sevoflurane and isoflurane). This is particular-
ly important as the combination of both Ab oligomerization
and tau hyperphosphorylation is necessary for AD pathology.
On the other hand, a very recent study has demonstrated
that surgery per se can also promote tau but not Ab pathology
independentlyof anaesthesia.81 It is, therefore, of concern that
general anaesthetics, surgery, or both can promote both pro-
cesses.
Agent-specific differences in neurotoxicity
Potential differences between isoflurane and desflurane on
mitochondrial dysfunction have been examined in mouse
models. Isoflurane but not desflurane can induce ROS
accumulation, open the mitochondrial permeability transition
pore, decrease mitochondrial membrane potential, reduce
ATP levels, release cytochrome c, induce caspase-3 activation,
and lead to impairment of learning and memory.19 82 Although
the clinical relevance of these differences between isoflurane
and desflurane remains to be determined, a pilot human
study suggests that surgery under anaesthesia with isoflurane,
but not desflurane, can lead to cognitive dysfunction in
patients.60
Protection for cognitive dysfunction byoverexpression
of heat-shock protein 72
Overexpression of heat shock protein 72 (Hsp72), which can
protect the brain from ischaemia, can also prevent memory
loss after orthopedic surgery under isoflurane anaesthesia
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in adult male mice.83 Although the mechanism for this
protection remains to be deciphered, it is likely multifactorial.
Wild-type mice suffered from memory impairment up to
7 days post-surgery because of effects of surgery, anaesthesia,
or both, whereas Hsp72 transgenic mice that overexpress
Hsp72 protein were significantly less impaired in both
hippocampal-dependent and hippocampal-independent
forms of memory.83
Conclusions
Mounting evidence exists from preclinical studies that general
anaesthetics are powerful modulators of neuronal develop-
ment and function. Although evidence from clinical studies in
paediatric and geriatric anaesthesiology is emerging, it is im-
portant for this line of research to be expanded. As general an-
aesthesia often cannot be avoided regardless of patient age, it
is important to understand the complex mechanisms and
effects involved in anaesthesia-induced neurotoxicity, and to
develop strategies for avoiding or limiting potential brain
injury. Studies towards those ends will permit more definitive
conclusions about potential neurotoxicity in humans, and
facilitate the establishment of recommendations to guide
clinical practice as definitive clinical data are likely to be elusive.
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